Overview
Status
Active
Registry date
2024-12-13
Share capital
5,000.00 PLN
Registered address
ul. Hugo Kołłątaja 6/3, 20-006 Lublin, Poland
Electronic delivery address
AE:PL-54272-36588-BCISD-17
Financials
Filing timeliness
1 of 1 financial statements was filed late (for 2025, 69 days late).
- 202522/09/2026
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Revenue
This companyUSD 23.96kMedianUSD 1.06mAverageUSD 22.40m
Net profit
This companyUSD -586.90kMedianUSD 37.33kAverageUSD 880.24k
Operating costs
This companyUSD 563.65kMedianUSD 922.77kAverageUSD 21.08m
Assets
This companyUSD 305.20kMedianUSD 608.93kAverageUSD 11.85m
Industry
Authorized Representatives
Dmytro Bilyy – Attorney-in-fact
Oleh Bilyy – Management Board Member
Hennadiy Pluhin – Management Board Member
Maksym Kishchak – President of the Management Board
Volodymyr Oznamets – Management Board Member
Manner of representation
Each member of the management board is authorized to make declarations on behalf of the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Oleh Bilyyage 68 | 20 | $270.12 | 20% |
Maksym Kishchakage 49 | 20 | $270.12 | 20% |
Volodymyr Oznametsage 66 | 20 | $270.12 | 20% |
Hennadiy Pluhinage 62 | 20 | $270.12 | 20% |
Oleksandr Schoholev | 20 | $270.12 | 20% |
The articles of association place no restrictions on share transfers.
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2024-12-23.
04 1020 1042 0000 8702 0615 3169
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Przedsiębiorstwo Dystrybucji Farmaceutycznej Slawexsp. z o.o. | $600,815,720.02 | slawex.com.pl | ||
| AsclepiosS.A. | $291,166,555.86 | asclepios.pl | ||
| LubfarmS.A. | $123,208,945.21 | lubfarm.pl | ||
| Camedica Paweł Harasimiuksp. k. | $18,691,613.15 | camedica.pl | ||
| Billmedsp. z o.o. | $5,738,714.60 | e.pl | ||
| Medcomplexsp. z o.o. | $5,193,830.09 | medcomplex.pl | ||
| Przedsiębiorstwo Zaopatrzenia Lecznictwa Cezal Lublinsp. z o.o. | $4,277,670.93 | cezal.lublin.pl | ||
| Bio-Novumsp. z o.o. | $3,459,663.10 | bio-novum.com | ||
| Myderm Laboratoriessp. z o.o. | $177,750.48 | myderm.com.pl | ||
| GROW Pharmasp. z o.o. | $15,020.86 | growpharma.pl |
Change history
| Date | Event | |
|---|---|---|
| 2025-05-06 | Address change (Ul. Anny Walentynowicz 10/1, 20-328, Lublin → Ul. Hugo Kołłątaja 6/3, 20-006, Lublin) | |
| 2024-12-13 | Entered in the register |
FAQ
The main business activity of Orisil-Pharm Poland focuses on wholesale of pharmaceutical goods.
The company was registered in the Polish National Court Register (KRS) on December 13, 2024.
The headquarters is located at: ul. Hugo Kołłątaja 6, 20-006 Lublin.
The share capital of the company is PLN 5,000 (approx. $1,351).
The latest available financial statement covers the period from December 12, 2024 to December 31, 2025.
In 2025, the company generated total revenue of USD 23,955.
No, the company recorded a net loss of USD 586,899 in 2025.
The largest operating cost category falls under external services. This category amounted to USD 547,217 in 2025, representing 97% of all operating expenses.
Last updated: 2026-09-22